Curaleaf Reports $216M Net Loss in 2024 Despite $1.34B Revenue
Curaleaf Holdings (TSX: CURA) reported a net loss of $216.2 million for 2024 which, while slightly improved from the $238.9 million loss
Read moreCuraleaf Holdings (TSX: CURA) reported a net loss of $216.2 million for 2024 which, while slightly improved from the $238.9 million loss
Read moreCuraleaf Holdings (TSX: CURA) reported its first quarter financial results yesterday after the closing bell. The company reported revenues of
Read moreCuraleaf Holdings (TSX: CURA) has refuted claims of being misquoted by Bloomberg in a recent article. The controversy arose from
Read moreCuraleaf Holdings (CSE: CURA) is officially leaving the Canadian Securities Exchange. The company has been approved to list its subordinate
Read moreCuraleaf Holdings (CSE: CURA) is looking to be the second US-based cannabis operator to list on the Toronto Stock Exchange.
Read moreCuraleaf’s attempt to obtain a medical cannabis license in Alabama has been met with controversy after concerns related to ownership
Read moreCuraleaf Holdings (CSE: CURA) saw mild growth in the second quarter in terms of topline revenue as the company turns
Read moreCuraleaf Holdings (CSE: CURA) is looking to be the second multi-state cannabis operator to list on the Toronto Stock Exchange.
Read moreCronos Group (TSX: CRON) has confirmed that it has received what amounts to “a number” of unsolicited indications of interest
Read moreCronos Group (TSX: CRON) jumped as much as 20% in mid-day trading today following the release of a rumor by
Read more